| Antiviral | EC50 ratio | Phenotype | Strain | Source | Marker | Assay | Reference |
|---|---|---|---|---|---|---|---|
| Foscarnet | 0.50 | No resistance | Laboratory strain, Clinical Isolate | Recombinant | Details | Immune restoration therapy for multidrug-resistant CMV disease in an allogenic stem cell transplant recipient. (May 2022) | |
| Ganciclovir | 3.00 | Intermediate level resistance | Laboratory strain, Clinical Isolate | Recombinant | Details | Immune restoration therapy for multidrug-resistant CMV disease in an allogenic stem cell transplant recipient. (May 2022) | |
| Cidofovir | 2.70 | Low level resistance | Laboratory strain, Clinical Isolate | Recombinant | Details | Immune restoration therapy for multidrug-resistant CMV disease in an allogenic stem cell transplant recipient. (May 2022) |
| Mutant | Resistances |
|---|---|
| T552N |
Ganciclovir:
|
| T552N |
Cidofovir:
|
| T552N |
Foscarnet:
|
| T552N |
Cidofovir:
|
| T552N |
Cidofovir:
|
| T552N |
Foscarnet:
|
| T552N |
Foscarnet:
|
| T552N |
Ganciclovir:
|
| T552N |
Ganciclovir:
|